To appreciate the Asian companies and individuals for their commendable performance and achievements during Calendar Year (CY) 2021, and noting that Asia is the new hub for potential growth and innovation, BioSpectrum Asia is setting the tone for an exciting opportunity in the form of BioSpectrum Asia Excellence Awards 2022.

These awards are an extension to observe and highlight the winners in the long battle to tackle the world's emerging health problems and find solutions. Since the years 2020 and 2021 were majorly affected by the COVID-19 pandemic, we saw the industry players relentlessly working towards developing novel solutions in the form of diagnostic tests, vaccine, monoclonal antibodies, drugs etc. to fight the emergency. 

Through these awards, BioSpectrum Asia is playing the role of picking tomorrow's winners, nudging today's entrepreneurs to achieve greater glory and honouring yesterday's key players who laid the foundation for success.

The BioSpectrum Asia Excellence Awards 2022 will be divided into two segments- Jury Special and Editor’s choice. The former segment has six categories associated with it- Emerging company or startup of the year; Technology/ product of the year; Woman Entrepreneur of the year; Entrepreneur of the year; Business person of the year; and Lifetime achievement award.

The latter segment will focus on these categories- Top Company in Bioprocessing; Top Company in Manufacturing Technology and Equipment; Top Company in API development; Top company for Analysis, Testing, and Quality Control; Top Company in Packaging & Drug Delivery Services; Top Company in Supply Chain, Logistics, and Distribution; Top Company in clinical research-based development; and Best Vaccine efforts of the year.

The Jury Special awards have well-defined criteria for which BioSpectrum's editorial team has brought together a six-member international jury to evaluate the shortlisted nominees.

BioSpectrum Asia Excellence Awards 2022 jury comprised of Prof Patrick Tan, Executive Director, Genome Institute of Singapore; Prof Gagandeep Kang, Laboratory Director, The Wellcome Trust Research Laboratory, India; Clare Blain, Chief Executive Officer, Life Sciences Queensland Limited, Australia; Dario Heymann, PhD, Chief Research Officer, Galen Growth, Singapore; Dr Satya Dash, Founding & Former Head Strategy; Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India; and Xinyi Tow, Director, Hello Tomorrow Asia Pacific, Singapore.        

Editor's Choice awards have been selected by the magazine's editorial team to turn the spotlight onto companies we believe will lead the way in the near future.

Back in 2006, the Asia edition of BioSpectrum was launched to chronicle the growth of the Life Sciences sector in the Asia region. Since its launch in March 2006 in Singapore, the magazine has been successful in bringing an Asian flavor to the world of life sciences, dominated for over a century by global companies.

BioSpectrum Asia’s inaugural Life Sciences Industry Award was conceptualised way back in 2008 and the event took place in 2009. After organising several successful annual events to celebrate and recognise leadership, entrepreneurship and innovation in Asia’s life sciences industry since 2009, and with a small gap in between, we are now back to continue this legacy forward in 2022.

We hereby invite you to attend the star-studded evening with your team at Lavender Ball Room, Hotel Fort Canning in Singapore on 2 December 2022.